Needham & Company LLC Reaffirms Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL)
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company LLC in a research report issued on Friday, Benzinga reports. They presently have a $35.00 price objective on the specialty pharmaceutical company’s stock. Needham & Company LLC’s price objective would suggest a potential upside of […]